Glenmede Trust’s Innophos Holdings, Inc. IPHS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-150
| Closed | -$4K | – | 2761 |
|
|
2020
Q1 | $4K | Hold |
150
| – | – | ﹤0.01% | 2748 |
|
|
2019
Q4 | $4K | Buy |
150
+28
| +23% | +$901 | ﹤0.01% | 2748 |
|
|
2019
Q3 | $3K | Buy |
122
+52
| +74% | +$1.5K | ﹤0.01% | 2813 |
|
|
2019
Q2 | $2K | Hold |
70
| – | – | ﹤0.01% | 2906 |
|
|
2019
Q1 | $2K | Hold |
70
| – | – | ﹤0.01% | 2879 |
|
|
2018
Q4 | $1K | Buy |
+70
| New | +$2.13K | ﹤0.01% | 2962 |
|
|
2017
Q3 | – | Sell |
-280
| Closed | -$15K | – | 2900 |
|
|
2017
Q2 | $15K | Hold |
280
| – | – | ﹤0.01% | 2015 |
|
|
2017
Q1 | $15K | Buy |
280
+98
| +54% | +$5.05K | ﹤0.01% | 2015 |
|
|
2016
Q4 | $9K | Buy |
+182
| New | +$8.84K | ﹤0.01% | 2140 |
|
|
2016
Q2 | – | Sell |
-198
| Closed | -$5K | – | 2777 |
|
|
2016
Q1 | $5K | Buy |
198
+48
| +32% | +$1.32K | ﹤0.01% | 2230 |
|
|
2015
Q4 | $3K | Sell |
150
-9,549
| -98% | -$336K | ﹤0.01% | 2408 |
|
|
2015
Q3 | $383K | Buy |
9,699
+9,588
| +8,638% | +$464K | ﹤0.01% | 1005 |
|
|
2015
Q2 | $4K | Buy |
+111
| New | +$6.03K | ﹤0.01% | 2312 |
|
Glenmede Trust's IPHS Position: Q2 2020 in Review
Glenmede Trust sold out of Innophos Holdings, Inc. (IPHS) in Q2 2020, closing a stake of 150 shares — an estimated $4K sold.
Glenmede Trust first reported a position in IPHS in Q2 2015 and held it in 13 quarters. The position peaked at $383K in Q3 2015. 1 fund tracked by Wall St. Rank holds IPHS as of Q2 2020.
- Glenmede Trust reported no remaining Innophos Holdings, Inc. position as of Q2 2020 after selling out during the quarter.
- Glenmede Trust sold 150 Innophos Holdings, Inc. shares in Q2 2020, an estimated $4K.
- Glenmede Trust first reported a position in Innophos Holdings, Inc. in Q2 2015 and held it in 13 quarters.
- Glenmede Trust's Innophos Holdings, Inc. position peaked at $383K in Q3 2015.
- 1 fund tracked by Wall St. Rank held Innophos Holdings, Inc. as of Q2 2020.
Based on Glenmede Trust's 13F filing for Q2 2020, filed 14 Aug 2020.